• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用一种新型钙通道阻滞剂尼群地平治疗老年高血压。

Treatment of hypertension in the elderly with a new calcium channel blocking drug, nitrendipine.

作者信息

Byyny R L, LoVerde M, Mitchell W

机构信息

Division of Internal Medicine, University of Colorado, Denver.

出版信息

Am J Med. 1989 Jan;86(1):49-55. doi: 10.1016/0002-9343(89)90229-5.

DOI:10.1016/0002-9343(89)90229-5
PMID:2642658
Abstract

PURPOSE

Treatment of hypertension in the elderly decreases cardiovascular morbidity and mortality. We hypothesized that nitrendipine would be efficacious in the treatment of hypertension in the elderly. We evaluated potential differences between nitrendipine and the commonly used drug hydrochlorothiazide (HCTZ).

PATIENTS AND METHODS

The study was conducted as a double-blind randomized clinical trial of nitrendipine or HCTZ. Thirty hypertensive subjects over age 60 with a median sitting blood pressure greater than or equal to 95 mm of Hg were recruited into the study. A diastolic blood pressure with treatment of less than 95 mm Hg with a 5 mm Hg or greater decrease from baseline was considered a successful response.

RESULTS

Nitrendipine decreased mean (+/- SEM) blood pressure from 163 +/- 3/102 +/- 1 to 142 +/- 2/89 +/- 2 mm Hg, and HCTZ decreased it from 164 +/- 4/102 +/- 1 to 143 +/- 5/91 +/- 2 mm Hg. A greater proportion of patients had a successful response with nitrendipine (81 percent) than with HCTZ (64 percent). The antihypertensive effect of nitrendipine twice daily appeared to be sustained for 24 hours. Blood pressure response to exercise was attenuated with both drugs. HCTZ caused gout, leg pains, muscle aches, hypokalemia, increased uric acid levels, and increased total cholesterol and triglyceride levels. Nitrendipine caused edema and tachycardia.

CONCLUSION

Nitrendipine significantly reduces blood pressure with few side effects and no adverse metabolic effects, and offers a reasonable alternative for treating hypertension in the elderly.

摘要

目的

治疗老年人高血压可降低心血管疾病的发病率和死亡率。我们假设尼群地平对治疗老年人高血压有效。我们评估了尼群地平和常用药物氢氯噻嗪(HCTZ)之间的潜在差异。

患者与方法

该研究作为一项关于尼群地平或HCTZ的双盲随机临床试验进行。招募了30名年龄超过60岁、坐位血压中位数大于或等于95毫米汞柱的高血压患者进入研究。治疗后舒张压低于95毫米汞柱且较基线下降5毫米汞柱或更多被视为成功反应。

结果

尼群地平使平均(±标准误)血压从163±3/102±1降至142±2/89±2毫米汞柱,氢氯噻嗪使其从164±4/102±1降至143±5/91±2毫米汞柱。尼群地平治疗取得成功反应的患者比例(81%)高于氢氯噻嗪(64%)。尼群地平每日两次的降压作用似乎可持续24小时。两种药物均可减弱运动对血压的反应。氢氯噻嗪导致痛风、腿痛、肌肉疼痛、低钾血症、尿酸水平升高以及总胆固醇和甘油三酯水平升高。尼群地平导致水肿和心动过速。

结论

尼群地平能显著降低血压,副作用少且无不良代谢影响,为治疗老年人高血压提供了合理的替代选择。

相似文献

1
Treatment of hypertension in the elderly with a new calcium channel blocking drug, nitrendipine.用一种新型钙通道阻滞剂尼群地平治疗老年高血压。
Am J Med. 1989 Jan;86(1):49-55. doi: 10.1016/0002-9343(89)90229-5.
2
Nitrendipine versus hydrochlorothiazide in hypertensive patients over 70 years of age.尼群地平与氢氯噻嗪治疗70岁以上高血压患者的疗效比较
Clin Pharmacol Ther. 1989 Mar;45(3):291-8. doi: 10.1038/clpt.1989.31.
3
Comparison of nitrendipine combined with low-dose hydrochlorothiazide to hydrochlorothiazide alone in mild to moderate essential hypertension.尼群地平联合小剂量氢氯噻嗪与单用氢氯噻嗪治疗轻至中度原发性高血压的比较。
J Cardiovasc Pharmacol. 1984;6 Suppl 7:S1105-8.
4
Antihypertensive therapy with nitrendipine: comparison with hydrochlorothiazide and propranolol.尼群地平的抗高血压治疗:与氢氯噻嗪和普萘洛尔的比较。
J Cardiovasc Pharmacol. 1988;12 Suppl 4:S55-8.
5
A comparison of felodipine and propranolol as additions to hydrochlorothiazide in the treatment of hypertension.
Eur J Clin Pharmacol. 1988;34(2):115-8. doi: 10.1007/BF00614545.
6
Systolic blood pressure reduction with olmesartan medoxomil versus nitrendipine in elderly patients with isolated systolic hypertension.奥美沙坦酯与尼群地平降低老年单纯收缩期高血压患者收缩压的比较
J Hypertens. 2007 Oct;25(10):2168-77. doi: 10.1097/HJH.0b013e328287ad0d.
7
Effects of nitrendipine and hydrochlorothiazide on postprandial blood pressure reduction and carbohydrate metabolism in hypertensive patients over 70 years of age.尼群地平和氢氯噻嗪对70岁以上高血压患者餐后血压降低及碳水化合物代谢的影响。
J Cardiovasc Pharmacol. 1988;12 Suppl 4:S59-63. doi: 10.1097/00005344-198806124-00011.
8
Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.安慰剂与活性治疗对老年单纯收缩期高血压患者疗效的随机双盲对照研究。欧洲收缩期高血压(Syst-Eur)试验研究者。
Lancet. 1997 Sep 13;350(9080):757-64. doi: 10.1016/s0140-6736(97)05381-6.
9
Randomised, double blind, multicentre comparison of hydrochlorothiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment: results of the HANE study. HANE Trial Research Group.氢氯噻嗪、阿替洛尔、尼群地平和依那普利在抗高血压治疗中的随机、双盲、多中心比较:HANE研究结果。HANE试验研究组
BMJ. 1997 Jul 19;315(7101):154-9. doi: 10.1136/bmj.315.7101.154.
10
Plasma lipid profiles and antihypertensive agents: effects of lisinopril, enalapril, nitrendipine, hydralazine, and hydrochlorothiazide.
Drug Intell Clin Pharm. 1988 Jul-Aug;22(7-8):546-50. doi: 10.1177/106002808802200704.